The cancer and cell biology division at Queensland Institute of Medical Research (QIMR) has discovered a new protein target that is critical to the genetic repair processes that promote cancer cell survival and keep them replicating. By discovering small molecules that inhibit this protein, Cancer Therapeutics CRC hopes to develop novel drugs that may stop cancers from growing and promote cancer cell death.
Julian Clark, CEO of Cancer Therapeutics, said: “This collaboration, with one of the leading research institutes in Australia, is the first project outside of our initial ‘core’ of participants. We expect that such collaborations between biological researchers and our drug developers can make a real impact on the treatment of cancer.”